The
rising prevalence of autoimmune diseases and consequent increase in healthcare
expenditure globally are the major factors driving the autoimmune
disease diagnostics market. Moreover, the favorable government initiatives
in various countries are also a factor leading to the growth of global
autoimmune disease diagnostics market. As stated by NIH, autoimmune disease is
one of the top ten causes of women deaths. The rapidly rising demand for
autoimmune disease diagnosis is a direct consequence of increasing incidences
of autoimmune diseases all over the world. Various laboratories have moved
toward installation of equipments which are able to conduct various tests
simultaneously and provide fast results. The slow turnaround time of
conventional autoimmune disease diagnostic procedures has encouraged various
laboratories to move towards automation. The active awareness campaigns aimed
to increase the awareness level regarding the diagnostics of diseases is the
factor expected to further fuel the global autoimmune disease diagnostics
market over the forecast period.
Browse
Detail Report with TOC @
The
autoimmune disease diagnostics market on the basis of product is segmented into
localized and systemic disease diagnostics. As of 2013, the local disease
diagnostics attributed the largest share in the market owing to the relatively
higher patient awareness level and the presence of huge procedure volumes. In
localized autoimmune disease segment, there are huge unmet needs of the
patients for various diseases such as type 1 diabetes. This factor is expected
to drive the localized autoimmune disease diagnostics market over the forecast
period. The systemic autoimmune disease diagnostics segment include diagnosis
of diseases such as lupus erythematosus (SLE), Ankylosing Spondylitis and
rheumatoid. The rheumatoid segment attributes the largest share in the market
owing to its most commonly usage in the diagnosis of autoimmune systemic
inflammatory diseases. The entanglement of expensive organ assessment test in
the rheumatoid disease is also a factor driving the systemic autoimmune
rheumatoid disease diagnostics market. The innovation in products such as
diagnosis based on drugs and presence of volume of tests at a large level are
the factors expected to further drive this segment.
The
global autoimmune disease diagnostics market on the basis of regions is
segmented into North America, Europe, Asia Pacific and RoW. As of 2013, North
America covered the largest share in the autoimmune disease diagnostics market
in terms of revenue. The existence of favorable government initiatives such as
Patient protection Act and Affordable Care Act and enlightened healthcare
infrastructure are some other factors driving the market in this region.
According to NIH, North America is accounted for the largest annual expenditure
in autoimmune disease diagnostics market. The rapidly increasing per capita
expenditure on healthcare is the factor expected to further fuel the growth of
this region. Europe is accounted for the second largest market as of 2013. The
technological advances in autoimmune disease diagnosis such as novel biomarkers
and potable diagnostic equipments and increasing incidences of autoimmune
diseases are the key factors for the growth of autoimmune disease diagnostics
market in this region. The factor expected for the further growth of this
region is the huge untapped opportunities mainly in the Eastern Europe.
Request
a Sample copy of This Report @http://www.hexaresearch.com/sample/6
The
rivalry levels for the Industry are expected to be moderately high over the
forecast period owing to the consolidated nature of the market. This
consolidated nature of the market has lead to the high presence of mergers and
acquisitions in the autoimmune disease diagnostics market. Manufacturers are facing
price based competition and they are under continuous pressure to bring
innovation in the products. Some of the key players in the global autoimmune
disease diagnostics market include Quest Diagnostics, Bio Rad, Hemagen
Diagnostics, Crescendo Bioscience, bioMeriux SA, Abott Diagnostics and Roche
Diagnostics. These players are constantly creating various competitive
strategies such as collaborations, expansions and acquisitions to keep a strong
foothold in the global autoimmune disease diagnostics market.
Table of
Contents
Chapter 1
Executive Summary
Chapter 2
Autoimmune Disease Diagnostics Industry Outlook
2.1 Market Segmentation
2.2 Market Size and Growth Prospects
2.3 Autoimmune disease diagnostics - Market
dynamics
2.3.1 Market Driver Analysis
2.3.1.2 Presence of research funding programs
2.3.1.4 Growing patient awareness levels
2.3.1.5 Technological innovation in the form
of lab automation
2.3.2 Market Restraint Analysis
2.3.2.1 Slow diagnostic result turnaround
times and lack of skilled healthcare practitioners
2.4 Key Opportunities Prioritized
2.5 Industry Analysis - Porter’s
2.6 Autoimmune Disease Diagnostics - PESTEL
Analysis
Browse
Full Report @
About
Us:
Hexa Research is a market research and
consulting organization, offering industry reports, custom research and
consulting services to a host of key industries across the globe. We offer
comprehensive business intelligence in the form of industry reports which help
our clients obtain clarity about their business environment and enable them to
undertake strategic growth initiatives.
Contact
Us:
Ryan Shaw
Hexa Research
Felton Office Plaza
6265 Highway 9
Felton, California 95018
United States
Phone: +1-800-489-3075
Email: sales@hexaresearch.com
Website - http://www.hexaresearch.com/
No comments:
Post a Comment